Latest California Healthline Stories
A breast cancer survivor and author has helped numerous patients explore the feelings awakened by their disease — and feel better.
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Although deaths from colorectal cancer are declining, researchers find rates of the disease among white men and women younger than 55 have spiked since the mid-1990s.
Thinking they were protected from insurance discrimination, many people got tested to see if they were likely to develop serious diseases. Legislation pushed by Republican leaders in Congress would leave them vulnerable.
Among hurdles: Older adults may have multiple illnesses that could complicate research or they might be unable to manage the commute.
A new study shows that a lower proportion of Asian women get timely follow-up appointments after abnormal mammograms than whites.
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
Researchers believe Californians, many of whom lost health coverage, delayed doctor visits that could have led to earlier detection. Now, with people seeking medical care under the Affordable Care Act, some experts expect to see an increase in late-stage cancers.